Overseas Business

Ruian's foreign trade's major business covers domestic and overseas pharmaceutical products, medical devices, medical expendable materials, chemicals, APIs as well as intermediate products and so on. Recent years, Ruian has made considerable development in contract project, drug registration, medical device registration and international purchasing as well as governmental bidding.

Our advantage

Ruian, acting as a bridge between Chinese and international medical world in the field of pharmaceutical business, has established close relationships with many partners in more than 100 countries and regions. Uphold the integrity of management and strictly abide the rules of international trade, the company has kept a good faith in all the relevant Chinese regulatory authorities as well as in the domestic and foreign financial institutions. We are committed to introduce the new products and advanced technology, equipment and management experience to China, as well as export the Chinese pharmaceutical products, techniques and equipment to all over the world.

As to the domestic marketing on pharmaceutical sales, Ruian has set up its sales network with more than 30 major cities and has built up an experienced sales team who familiarizes both medical knowledge and foreign languages to develop the business in the form of exclusive agency, regional agency, domestic distribution and market promotion.

We have a group of high-quality and professional team with rich experience in foreign trade business, in the field of medicine import and export. By the good faith and professional services, Ruian has won the trust of customers at home and abroad. We successively establish long-term stable relations of cooperation with Denmark ApodanNordic, Italian Plastod, German BioMedical b. Baumann and other international pharmaceutical enterprises. Ruian own a team of employees of master and doctor's degree etc, who are experienced staff of professional knowledge and strong business ability. They all played a positive role in developing the company's foreign trade channels, such as developing the European market, American market African and southeast Asian market.